Periodic Reporting for period 4 - HybridHeart (Development of the first fully biocompatible, soft actuated heart: combining in situ tissue engineering and soft robotics)

The Hybrid Heart consortium envisions to develop and bring to the clinic soft biocompatible artificial organs. These will consist of a soft robotics shell with actuators (‘artificial muscles’) and sensors, enabling completely natural motion. The inner lining and structures...